FORGE: A Novel Scoring System to Predict the MIB-1 Labeling Index in Intracranial Meningiomas

SIMPLE SUMMARY: Meningiomas are predominantly benign intracranial tumors, and surgical therapy represents the treatment of choice. However, the risk of recurrence and scheduling of follow-up intervals are significantly influenced by immunohistochemical items such as the MIB-1 labeling index. To date...

Descripción completa

Detalles Bibliográficos
Autores principales: Wach, Johannes, Lampmann, Tim, Güresir, Ági, Schuss, Patrick, Vatter, Hartmut, Herrlinger, Ulrich, Becker, Albert, Hölzel, Michael, Toma, Marieta, Güresir, Erdem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306435/
https://www.ncbi.nlm.nih.gov/pubmed/34298854
http://dx.doi.org/10.3390/cancers13143643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306435/
https://www.ncbi.nlm.nih.gov/pubmed/34298854
http://dx.doi.org/10.3390/cancers13143643

Ejemplares similares